cariporide has been researched along with ticagrelor in 1 studies
| Studies (cariporide) | Trials (cariporide) | Recent Studies (post-2010) (cariporide) | Studies (ticagrelor) | Trials (ticagrelor) | Recent Studies (post-2010) (ticagrelor) |
|---|---|---|---|---|---|
| 409 | 10 | 79 | 2,425 | 594 | 2,246 |
| Protein | Taxonomy | cariporide (IC50) | ticagrelor (IC50) |
|---|---|---|---|
| P2Y purinoceptor 13 | Homo sapiens (human) | 1.398 | |
| P2Y purinoceptor 12 | Homo sapiens (human) | 1.1028 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhammouri, A; Cohen, MV; Cui, L; Downey, JM; Yang, XM | 1 |
1 other study(ies) available for cariporide and ticagrelor
| Article | Year |
|---|---|
Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart.
Topics: Adenosine; Adenosine Monophosphate; Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Guanidines; Hypothermia, Induced; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Sulfones; Ticagrelor | 2013 |